Director RWE

Director RWE & Innovative Evidence

Hybrid - London

Outside IR35

Up to £815 a day

Job Purpose

The Director RWE & Innovative Evidence is responsible for developing and implementing

evidence strategies that deliver innovative and scientifically robust evidence to Therapeutic Areas (TAs) across the Innovative Medicine (IM) organization. Evidence strategies

inform business decisions about the research and development of products and support healthcare decisions by patients, physicians, health authorities, payers, and policymakers. The incumbent will serve as an expert for real world evidence (RWE) and integrated evidence, enabling cross-functional teams in becoming leaders in developing and executing integrated evidence strategies that include RWE.

The Director RWE & Innovative Evidence also contributes significantly to internal enterprise-wide and external cross-stakeholder initiatives that shape our business and healthcare environments. This role requires excellent scientific and technical expertise in real world data and observational research as well as a strong understanding of product and disease area strategies, our business, and healthcare environments. Success

also requires robust strategic thinking, leadership, collaboration and communication skills, as well as an entrepreneurial mindset, to work with and through others, to reimagine the way we use innovative evidence to develop and deliver medicines for patients.

The Director RWE & Innovative Evidence will drive the development of integrated evidence approaches, techniques and standards as well as working closely with TAs, NIBR, GDD, Access and Medical and key countries to enable innovative evidence and sharing of best practices across geographies.

Job Description

Major Accountabilities

1. Develop and drive overarching innovative integrated evidence strategies, in collaboration with internal partners, to ensure that the value of our medicines is

fully supported by evidence.

2. Act as a thought-leader and internal change agent on matters pertaining to the overall creation and implementation of Innovative Medicines (IM) portfolio RWE / Integrated Evidence strategies and tactics.

3. Ask the right scientific questions, understand the evidence needs to optimize approval, access and clinical adoption of our medicines, and ideate and make recommendations on fit-for-purpose data and integrated evidence solutions.

4. Deliver high quality, rigorous, and fit-for-purpose evidence solutions according to priorities and opportunities to impact patients and society.

5. Closely collaborate with internal and external partners ensuring scientific rigor in evidence strategy, study design and analyses.

6. Lead partnerships with Medical Societies, Academic Institutes, payer bodies, other data owners to build meaningful RWD research collaborations.

7. Lead or contribute significantly to cross-functional, enterprise-wide and external evidence initiatives as well as to new and innovative data and analytic platforms, methodological approaches and technologies, which enable broader and more effective use of integrated evidence to reimagine medicine.

8. Work closely with key countries to develop timely, meaningful and robust evi(1)dence to support product value demonstration aligned with local needs (patient access, reimbursement, medical education, and patient advocacy).

9. Define and deliver on goals and objectives, identify opportunities, gaps and priorities, and contribute to best practice standards.

10. Ensure appropriate prioritization of funding and resources, informed by tradeoff, valuation analysis where appropriate and aligned with TA strategy.

11. Stay abreast of emergent applications, external insights, trends and requirements, and internal learnings, and positively drive development of innovative evidence.

12. Develop strong internal and external partnerships to promote effective collaborations. Lead by example in promoting a collaborative and entrepreneurial culture and mindset. Be an advocate and champion by engaging support for innovative ideas and solutions and ensuring a broad understanding of the value of RWE and integrated evidence to the product value demonstration both globally and in key markets.

Key Performance Indicators (Indicate how performance for this job will be measured)

1. Timely creation of compelling and robust evidence, which support and enhances product development to optimize regulatory approval, patient access and clinical adoption in priority disease areas.

2. High quality integrated evidence plans (IEP) across the TAs and product lifecycle, which utilize best-in-class innovative approaches.

3. Consistent approach towards RWE generation, ensuring scientific rigor, aligned with RWE external and internal guidance.

Job Dimensions (Indicate key facts and figures)

Ideal Background (State the preferred education and experience level)

Education: Advanced degree or equivalent education/degree in

life science/healthcare required. MBA or equivalent preferred

Languages: English (oral and written)

Experience/ Professional requirements:

• 7+ years industry and/or relevant experience acquired at biopharmaceutical companies, academia, healthcare provider / Payer / HTA, or relevant consultancy companies

• Deep understanding and experience of RWD/RWE and/or related disciplines to generate scientifically rigorous and impactful evidence, both from prospective and retrospective studies, including secondary data sources.

• Strong understanding of drug development with proven ability to identify and deliver impactful evidence from retrospective and prospective studies to optimize regulatory approval, market access and clinical adoption.

• Strong cross-functional experience working with Clinical Development, Commercial, Market Access, HEOR, Medical, Safety, and Regulatory colleagues.

• Deep understanding of and experience with research methodology and statistical methods related to retrospective and prospective clinical data analysis, and observational and/or epidemiological research.

• Demonstrated track record leading and executing research projects using RWD from claims, electronic health records, registries, biobanks, or digital applications, including publications.

• Considerable experience in collaborating with quantitative scientists and analysts,

• Strong leadership skills, with an ability to motivate and inspire teams and manage change.

• Proven ability to develop and successfully implement new strategies and ideas.

• Strong communication skills. Proven ability to translate and effectively communicate complex technical concepts and innovative evidence solutions to diverse audiences.

• Robust organizational, interpersonal, collaboration and influencing skills

• Results focused, ability to meet difficult timelines in a dynamic environment

• Must be able to organize, prioritize and work effectively in a constantly changing environment.

Strongly Preferred

Skills/Requirements

• Extensive industry experience generating evidence for assets across different stages of drug development.

• Prior experience, including a strong understanding of its culture and processes.

• Prior leadership experience with international, multidisciplinary drug development, product teams or country organizations (US preferred).

• Strong external presence and connectivity, including an active network in RWE.

• Deep understanding of pharmaceutical value chain and its business processes.7

If you are interested please apply or send your CV to